HQ Team
March 16, 2026: Academy Award-winning actress Lupita Nyong’o has ignited a vital global conversation about uterine fibroids after sharing a powerful social media post revealing her ongoing struggle with 77 benign fibroid tumors. The “Black Panther” star, who first underwent surgery to remove 23 fibroids in 2014, recently disclosed that over 50 have returned—one as large as an orange—highlighting the persistent nature of a condition that affects millions of women worldwide.
A silent epidemic of staggering scale
Uterine fibroids, also known as myomas or leiomyomas, represent one of the most common gynecological conditions globally. In the United States alone, an estimated 26 million women between ages 15 and 50 have fibroids, with more than 15 million experiencing debilitating symptoms including heavy menstrual bleeding, pelvic pain, and bladder dysfunction. The racial disparity is stark: by age 50, over 80% of Black women will develop fibroids compared to approximately 70% of white women, with Black women typically experiencing earlier onset, larger tumors, and more severe symptoms.
Globally, the burden is immense and growing. Research analyzing Global Burden of Disease data from 1990 to 2021 found that incident cases worldwide rose from 6 million to over 10 million annually, with prevalent cases increasing from 65.7 million to nearly 120 million .
Eastern Europe currently reports the highest incidence rates (610 per 100,000), while South Asia shows the fastest growth in case numbers.
The World Health Organization recognizes fibroids as a significant contributor to disability-adjusted life years (DALYs) among reproductive-age women, with low and middle-income regions bearing disproportionate burdens.
Beyond hysterectomy: Medical innovation expands options
Despite the prevalence, treatment has historically been limited, often defaulting to hysterectomy. However, medical alternatives that preserve fertility and minimize recovery time are available.. “Fibroids are treatable with more than a hysterectomy,” emphasizes Dr. Jocelyn Carlo, director of gynecologic surgery at Hackensack Meridian Jersey Shore University Medical Center. “It is vital that women feel empowered to speak up about their symptoms and seek expert care” [Original source: provided text].
Dr Shore’s institution recently incorporated the Sonata® Transcervical Fibroid Ablation system, an FDA-cleared incision-free procedure using ultrasound-guided heat ablation via the cervix. This joins established minimally invasive options including the uterine artery embolization and Acessa® Laparoscopic Radiofrequency Ablation system, which demonstrated 81.9% reduction in menstrual bleeding and 98% patient recommendation rates at 12 months in pivotal trials.
“By integrating cutting-edge technologies like the Sonata system, we are fundamentally changing how we manage fibroids,” states Dr. Michele Isaacs, an obstetrician-gynecologist specializing in fibroid treatment.
Risk factors
Multiple factors increase fibroid risk: Vitamin D deficiency, early menstruation onset, obesity, and diets high in red meat. The racial disparities suggest genetic and environmental components requiring further investigation, particularly in underrepresented populations. Recent research has also revealed alarming cardiovascular connections. A 2025 study of 2.7 million U.S. women found those with fibroids had over 80% higher 10-year heart disease risk, with women under 40 facing 3.5 times greater risk.
Nyong’o’s is campaigning for more awareness of a highly prevelant disease that often gets dismissed as another woman problem. Her advocacy extends to partnering with the Foundation for Women’s Health to campaign for noninvasive treatment research.
Advocacy and access
Advocacy and access to quality healthcare are prime factors in treatment. As someone from a developing country with a strong history of the disease in the family, my class privilege has led to excellent access to care. Nearly 45 years ago my parent underwent a hysteroctomy due to fibroids the size of a small melon and recovery time was a month. Sister had a fibroid pressing down on a growing fetus. Excellent care saw a full term pregnancy and removal of the huge fibroid. Constant supervision, access to good doctors and awareness were the key.
What is concerning is that almost half a century later, the techniques might have improved, but access, advocacy and awarenss are still a problem for females even in the developed countries!!!